BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8540314)

  • 1. Two cases of early colorectal cancer associated with gastric adenoma detected by serum pepsinogen screening method.
    Shimizu Y; Kakei N; Wada T; Yahagi N; Kido M; Ishihama S; Tsukada S; Matsushima M; Ichinose M; Miki K
    Adv Exp Med Biol; 1995; 362():149-54. PubMed ID: 8540314
    [No Abstract]   [Full Text] [Related]  

  • 2. A minute gastric cancer detected by a new screening method using serum pepsinogen I and II.
    Yahagi N; Miki K; Ichinose M; Kakei N; Matsushima M; Kido M; Shimizu Y; Ishihama S; Tsukada S; Kurokawa K
    Adv Exp Med Biol; 1995; 362():145-8. PubMed ID: 8540313
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical significance of colonoscopic examination in patients with early stage of gastric neoplasm undergoing endoscopic submucosal dissection.
    Lee KJ; Kim JH; Kim SI; Jang JH; Lee HH; Hong SN; Lee SY; Sung IK; Park HS; Shim CS; Han HS
    Scand J Gastroenterol; 2011 Nov; 46(11):1349-54. PubMed ID: 21905975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do we need colonoscopy in patients with gastric adenomas? The risk of colorectal adenoma in patients with gastric adenomas.
    Yang MH; Son HJ; Lee JH; Kim MH; Kim JY; Kim YH; Chang DK; Rhee PL; Kim JJ; Rhee JC
    Gastrointest Endosc; 2010 Apr; 71(4):774-81. PubMed ID: 20363417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic aspiration mucosectomy as curative endoscopic surgery; analysis of 24 cases of early gastric cancer.
    Torii A; Sakai M; Kajiyama T; Kishimoto H; Kin G; Inoue K; Koizumi T; Ueda S; Okuma M
    Gastrointest Endosc; 1995 Nov; 42(5):475-9. PubMed ID: 8566641
    [No Abstract]   [Full Text] [Related]  

  • 6. [Colonoscopic screening of asymptomatic individuals with a family history of colorectal cancer].
    Maxim M; Trifan A; Stanciu C
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):993-7. PubMed ID: 21500448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects.
    Yoshihara M; Sumii K; Haruma K; Kiyohira K; Hattori N; Kitadai Y; Komoto K; Tanaka S; Kajiyama G
    Am J Gastroenterol; 1998 Jul; 93(7):1090-6. PubMed ID: 9672336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation on a gastric mass survey-comparison with gastric mass screening using photofluorography and that using serum pepsinogen].
    Tomooka Y
    Nihon Koshu Eisei Zasshi; 1996 Feb; 43(2):118-25. PubMed ID: 8901216
    [No Abstract]   [Full Text] [Related]  

  • 9. [Gastric adenocarcinoma and carcinoid].
    Cunha P; Cunha JF; Burnay MO; Galhordas A; Fernandes R; Calinas F
    Acta Med Port; 1998 Jun; 11(6):577-80. PubMed ID: 9773539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early adenocarcinoma colliding with a pyloric gland adenoma in the gastric cardia.
    Pei Q; Shi Y; Jing H
    Gastrointest Endosc; 2019 Sep; 90(3):522-523.e1. PubMed ID: 31022395
    [No Abstract]   [Full Text] [Related]  

  • 11. The usefulness of gastric mass screening using serum pepsinogen levels compared with photofluorography.
    Yoshihara M; Sumii K; Haruma K; Kiyohira K; Hattori N; Tanaka S; Kajiyama G; Shigenobu T
    Hiroshima J Med Sci; 1997 Jun; 46(2):81-6. PubMed ID: 9232936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mass screening of stomach neoplasms by serum pepsinogen analysis].
    Miki K
    Nihon Naika Gakkai Zasshi; 1992 May; 81(5):654-9. PubMed ID: 1512496
    [No Abstract]   [Full Text] [Related]  

  • 13. Synchronous colorectal neoplasms in patients with colorectal cancer: predisposing individual and familial factors.
    Piñol V; Andreu M; Castells A; Payá A; Bessa X; Jover R;
    Dis Colon Rectum; 2004 Jul; 47(7):1192-200. PubMed ID: 15164252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A spongiform mass in the stomach: pyloric gland adenoma with a transition to adenocarcinoma].
    Oh MG; Cho SJ; Lee JH; Kook MC; Park SY
    Korean J Gastroenterol; 2010 Jul; 56(1):1-5. PubMed ID: 20664311
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pepsinogen].
    Miki K
    Nihon Rinsho; 1995 May; 53(5):1198-202. PubMed ID: 7602778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical application of serum pepsinogen I and II levels for mass screening to detect gastric cancer.
    Miki K; Ichinose M; Ishikawa KB; Yahagi N; Matsushima M; Kakei N; Tsukada S; Kido M; Ishihama S; Shimizu Y
    Jpn J Cancer Res; 1993 Oct; 84(10):1086-90. PubMed ID: 8226283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Multiple synchronous primary gastric cancers].
    Britvin AA; Zeĭnalov FA
    Vestn Khir Im I I Grek; 1984 Nov; 133(11):71. PubMed ID: 6523667
    [No Abstract]   [Full Text] [Related]  

  • 18. Metachronous primary cancers of colon and stomach.
    Ahmad Z; Memon A; Minhas K
    J Coll Physicians Surg Pak; 2008 Feb; 18(2):118-20. PubMed ID: 18454902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Multiple primary carcinomatosis of the gastrointestinal tract].
    Styrkina LI; Lukin VV; Troitskaia TV
    Sov Med; 1991; (10):88-9. PubMed ID: 1801250
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of the validity of three biomarkers for gastric cancer screening: carcinoembryonic antigen, pepsinogens, and high sensitive C-reactive protein.
    Chung HW; Kim JW; Lee JH; Song SY; Chung JB; Kwon OH; Lim JB
    J Clin Gastroenterol; 2009 Jan; 43(1):19-26. PubMed ID: 18648315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.